Neose Technologies, Inc.

Magnolia Nutritionals, L.l.c.

Other

Neose Pharmaceuticals, Inc.

Edward J McGuire

Stephen A Roth

Steven J Catani

Juan L Navia

Paul M Simon

Dennis H Langer

David A Zopf

The present invention relates to a process of preparing commercial quantities of glucose and/or fructose from sucrose, a process of preparing commercial quantities of glucose and a polyfructan from sucrose, a reactor for practicing same, a process of preparing commercial quantities of fructose and a polyglucan from sucrose and a reactor for practicing same.

Process for processing sucrose into glucose and fructose

The invention relates to methods for attenuating xenograft rejection in humans and old world monkeys, using oligosaccharides containing a Gal.alpha.1-3Gal motif, to neutralize or remove anti-.alpha.Gal antibodies. The invention additionally relates to methods for site directed activation of the complement cascade or host leukocytes using oligosaccharides containing a Gal.alpha.1-3Gal motif to target anti-.alpha.Gal antibodies. The invention further relates to pharmaceutical compositions that may be used in the practice of the invention. Such compositions contain, as the active ingredient, an oligosaccharide containing a Gal.alpha.1-3Gal motif effective in binding anti-.alpha.Gal antibodies in vivo or ex vivo.

Methods of using .alpha.Gal oligosaccharides as immune system targeting

The present invention relates to a process of preparing commercial quantities of glucose from sucrose, a process of preparing commercial quantities of glucose and a branched fructan from sucrose, a reactor for practicing same.

Process for processing sucrose into glucose

A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I

Method for inhibiting H. pylori infection in mammalian tissue

Method for treating and inhibiting gastric and duodenal ulcers

A composition for treating and/or inhibiting gastric and duodenal ulcers, comprising an oligosaccharide selected from the group consisting of Formula I ##STR1## or a mixture thereof; wherein:

Compositions for treating and inhibiting gastric and duodenal ulcers

An artificial Christmas tree has a trunk. The trunk has a branch retaining rod and a plurality of branch retaining ports in the branch retaining rod. There is a branch retaining rod horizontal support member releasably attached to one end of the branch retaining rod. A branch retaining rod vertical support member is attached to another end of the branch retaining rod. There are a plurality of flexible branches. Each flexible branch has a flexible member and a plurality of artificial needles retained in the flexible member. The flexible member has an insertion end for insertion into a branch retaining port. There is an ornament retaining member releasably attached to the flexible branches. The ornament retaining member has a hinged retaining clip and a spring. The spring is attached to and biases the hinged retaining clip from an open position to an closed position. The branch retaining rod also has at least two interconnectable sections releasably and threadingly connected together or alternatively foldingly connected.

Growing community of inventors

Furlong, PA, United States of America

Edward J McGuire